- Home
- CRIS vs VVOS Comparison
CRIS vs VVOS Comparison
Compare CRIS & VVOS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CRIS
- VVOS
- Stock Information
- Founded
- CRIS 2000
- VVOS 2016
- Country
- CRIS United States
- VVOS United States
- Employees
- CRIS N/A
- VVOS N/A
- Industry
- CRIS Biotechnology: Biological Products (No Diagnostic Substances)
- VVOS Medical Specialities
- Sector
- CRIS Health Care
- VVOS Health Care
- Exchange
- CRIS Nasdaq
- VVOS Nasdaq
- Market Cap
- CRIS 22.9M
- VVOS 27.3M
- IPO Year
- CRIS 2000
- VVOS 2020
- Fundamental
- Price
- CRIS $1.77
- VVOS $3.40
- Analyst Decision
- CRIS Strong Buy
- VVOS Strong Buy
- Analyst Count
- CRIS 2
- VVOS 2
- Target Price
- CRIS $16.50
- VVOS $6.25
- AVG Volume (30 Days)
- CRIS 75.9K
- VVOS 140.4K
- Earning Date
- CRIS 11-13-2025
- VVOS 11-13-2025
- Dividend Yield
- CRIS N/A
- VVOS N/A
- EPS Growth
- CRIS N/A
- VVOS N/A
- EPS
- CRIS N/A
- VVOS N/A
- Revenue
- CRIS $11,405,000.00
- VVOS $14,393,000.00
- Revenue This Year
- CRIS $1.41
- VVOS $3.83
- Revenue Next Year
- CRIS $7.46
- VVOS $25.27
- P/E Ratio
- CRIS N/A
- VVOS N/A
- Revenue Growth
- CRIS 12.24
- VVOS 2.65
- 52 Week Low
- CRIS $1.02
- VVOS $1.98
- 52 Week High
- CRIS $6.44
- VVOS $7.95
- Technical
- Relative Strength Index (RSI)
- CRIS 52.53
- VVOS 34.47
- Support Level
- CRIS $1.63
- VVOS $3.80
- Resistance Level
- CRIS $1.95
- VVOS $4.63
- Average True Range (ATR)
- CRIS 0.14
- VVOS 0.37
- MACD
- CRIS 0.02
- VVOS -0.10
- Stochastic Oscillator
- CRIS 45.59
- VVOS 3.93
About CRIS Curis Inc.
Curis Inc is a biotechnology company that develops and commercializes drugs and therapies in the immuno-oncology and precision oncology therapeutic areas. The company targets solid tumors, diffuse large B-cell lymphoma, solid tumors or lymphomas, hematological cancers, and others. Its pipeline products include Fimepinostat, CA-170, CA-4948, CA-327, and Erivedge.
About VVOS Vivos Therapeutics Inc.
Vivos Therapeutics Inc is a medical technology company. It is focused on the development and commercialization of a technology offering non-surgical, non-invasive, non-pharmaceutical, and low-cost solution for patients with sleep-disordered breathing (SDB), including mild-to-moderate obstructive sleep apnea (OSA). The company provides treatment for mild-to-moderate OSA involves customized oral appliances and protocols called the Vivos System. The Vivos systme is an therapeutic protocol, which often combines the use of customized oral appliance specifications and proprietary clinical treatments developed by company and prescribed by specially trained dentists in cooperation with their medical colleagues.